PROTOCOL,PUB_ID,RX_CODE,RX_LABEL,AGE,SEX,RACE,HISPANIC,DISC_FL,DISC_RSN,DISC_RSN_O,EARLY_TERM_FL,TERM_RSN,TERM_AE,NUM_VAC_RECD
120,120-001,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",32,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-002,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",20,Female,White,Yes,No,,,No,Scheduled exit visit/end of study,No,4
120,120-003,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",33,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-004,P4,"Placebo mo(0,1,3,6)",26,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,1
120,120-005,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",19,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-006,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-007,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",38,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-008,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",27,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-009,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",23,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-010,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",19,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-011,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",22,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-012,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",37,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-013,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",19,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-014,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",25,Female,Multiracial,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-015,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",18,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-016,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",37,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-017,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",23,Female,Multiracial,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-018,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",20,Female,White,No,Yes,Participant relocated,,Yes,"Participant relocated, no follow-up plan",No,3
120,120-019,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",26,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-020,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",38,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-021,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",38,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-022,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",24,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-023,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",20,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-024,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",25,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-025,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",20,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-026,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",24,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-027,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",31,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-028,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-029,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",33,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-030,P4,"Placebo mo(0,1,3,6)",23,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-031,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",24,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-032,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",29,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-033,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",32,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-034,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",26,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-035,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",33,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-036,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",31,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-037,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",20,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-038,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",23,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-039,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",20,Male,Black/African American,No,No,,,Yes,Participant unable to adhere to visit sc,No,4
120,120-040,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",20,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-041,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",22,Female,Black/African American,No,No,,,Yes,Participant unable to adhere to visit sc,No,4
120,120-042,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",34,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-043,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",26,Female,White,Yes,No,,,No,Scheduled exit visit/end of study,No,4
120,120-044,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",26,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-045,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",22,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-046,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",38,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-047,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",22,Female,Black/African American,No,No,,,Yes,Unable to contact participant,No,4
120,120-048,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",18,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-049,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",25,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-050,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",25,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-051,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",37,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-052,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",34,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-053,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",39,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-054,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-055,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",21,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-056,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",22,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-057,P4,"Placebo mo(0,1,3,6)",19,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-058,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",23,Male,Black/African American,No,No,,,Yes,Unable to contact participant,No,4
120,120-059,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",26,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-060,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",31,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-061,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",34,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-062,P4,"Placebo mo(0,1,3,6)",30,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-063,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",30,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-064,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",22,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-065,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",22,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-066,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",22,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-067,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",20,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,3
120,120-068,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-069,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",19,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-070,P4,"Placebo mo(0,1,3,6)",24,Male,White,Yes,No,,,No,Scheduled exit visit/end of study,No,4
120,120-071,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",28,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-072,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",27,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-073,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",31,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-074,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",31,Male,White,Yes,No,,,No,Scheduled exit visit/end of study,No,4
120,120-075,P4,"Placebo mo(0,1,3,6)",24,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-076,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",27,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-077,P4,"Placebo mo(0,1,3,6)",36,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-078,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",19,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-079,P4,"Placebo mo(0,1,3,6)",22,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-080,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",21,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-081,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",34,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-082,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",22,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-083,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",22,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-084,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",23,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-085,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-086,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",26,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-087,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",20,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-088,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",27,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-089,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",28,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-090,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",23,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-091,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",30,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-092,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",26,Male,White,No,Yes,Reactogenicity symptom,,No,Scheduled exit visit/end of study,No,3
120,120-093,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",24,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-094,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",25,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-095,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",24,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-096,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",27,Female,Multiracial,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-097,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",25,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-098,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",25,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-099,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",26,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-100,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",21,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-101,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",23,Male,White,No,No,,,Yes,"Participant relocated, no follow-up plan",No,4
120,120-102,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",25,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-103,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",21,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-104,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",32,Male,Multiracial,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-105,P4,"Placebo mo(0,1,3,6)",18,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-106,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",27,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-107,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",24,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-108,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",20,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-109,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-110,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",23,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-111,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",19,Female,Multiracial,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-112,P4,"Placebo mo(0,1,3,6)",37,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-113,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",29,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-114,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",23,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-115,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",25,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-116,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",22,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-117,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",19,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-118,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",19,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-119,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-120,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",20,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-121,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",27,Female,White,Yes,No,,,Yes,"Other, specify",No,4
120,120-122,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",31,Female,White,No,No,,,Yes,"Other, specify",No,4
120,120-123,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",23,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-124,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",21,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-125,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",24,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-126,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",22,Female,Asian,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-127,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",35,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-128,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",31,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-129,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",22,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-130,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",28,Female,Black/African American,No,No,,,Yes,Participant unable to adhere to visit sc,No,4
120,120-131,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",30,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-132,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",24,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-133,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",19,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-134,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",24,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-135,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",37,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-136,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",30,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-137,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",34,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-138,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",22,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-139,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",20,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-140,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",35,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-141,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",34,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-142,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",27,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-143,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",22,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-144,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",29,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-145,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",24,Male,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-146,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",21,Female,Asian,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-147,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",22,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-148,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-149,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",26,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-150,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",26,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-151,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",26,Female,Black/African American,No,Yes,Participant relocated,,Yes,"Participant relocated, no follow-up plan",No,3
120,120-152,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",31,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-153,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",20,Female,Black/African American,No,Yes,Participant relocated,,Yes,"Participant relocated, no follow-up plan",No,1
120,120-154,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",40,Female,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-155,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",21,Male,Black/African American,No,Yes,Participant relocated,,Yes,"Participant relocated, no follow-up plan",No,1
120,120-156,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",21,Male,Black/African American,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-157,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",24,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-158,T1,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/MF59 mo(3,6)",24,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-159,T3,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B Low mo(3,6)",21,Female,White,No,No,,,No,Scheduled exit visit/end of study,No,4
120,120-160,T2,"ALVAC-HIV mo(0,1), ALVAC-HIV + Protein/AS01B High mo(3,6)",22,Female,Multiracial,No,No,,,No,Scheduled exit visit/end of study,No,4